PhD Žan Toplak

PhD Žan Toplak
no.: 52375 source: ARIS

researcher – not employed in research organisation
  zan.toplakat signffa.uni-lj.si
Edit
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
169.6
A''
35.77
A'
110.2
A1/2
129.16
CI10
104
CImax
34
h10
6
A1
0.63
A3
0
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 8  126  101  12.63 
Scopus 8  130  103  12.88 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
2nd cycle master's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2018 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2021 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J1-3031  Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance   10/1/2021 - 9/30/2025  PhD Nace Zidar   1,187 
2. J1-3030  MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance   10/1/2021 - 9/30/2025  PhD Lucija Peterlin Mašič   1,098 
3. J1-1717  Development of novel Hsp90 inhibitors with anticancer activity   7/1/2019 - 6/30/2023  PhD Tihomir Tomašić   2,107 
4. N1-0098  Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity   1/1/2019 - 12/31/2022  PhD Lucija Peterlin Mašič   1,000 
5. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,481 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2022 - 12/31/2027 PhD Stanislav Gobec   5,973 
2. P1-0208  Medicinal chemistry - drug design, synthesis and evaluation   1/1/2015 - 12/31/2021 PhD Stanislav Gobec   6,671 
Confirmation required
Views history
Favourite